Neuroradiological interventions, particularly neuroendovascular therapies, have recently seen an increasing demand from an immense patient population in our area of the world, and this demand has been met to a large part by growing support and the active performance of ambitious young neurointerventionists. In spite of such a privileged situation which currently occupies the top market share, there still is a lack of leading clinical reports drawing from our large clinical case series experience. Furthermore, we continue to follow in the footsteps of Western countries in regards to clinical experience with new devices, primarily due to less established clinical research systems and other administrative issues such as delays in new device approval. Compounding this dilemma, perhaps the patients suffer most, especially because of the biased distribution of resources and insufficient number of neuroendovascular therapists in developing countries, resulting in less chances for patients to undergo minimally invasive therapy by endovascular or neurointerventional approaches.
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Therefore, we must meet these expectations of our patients and the well-being of the public with enthusiasm, seeking to challenge our borders and barriers with honest and pure pursuit of the academic and educational road to the summit and beyond. One of the most important issues which confronts us today is the need to acquire the basic knowledge necessary to understand and formulate appropriate therapeutic and research strategies as well as to master up-to-date techniques and thereby, not fall behind world trends. From an academic point of view, which is expressed in the timely theme ''Strengthening Foundations and Exploring New Concepts'', I firmly believe the 13 th Congress of the AAFITN organised by Dr Jeyaledchumy Mahadevan will open the door for a brighter future. I hope this journal will bring us novel knowledge as well as highlight areas of future study according to the theme of the 13 th Congress of the AAFITN.
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